| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.2003.01.088 |
| P698 | PubMed publication ID | 14581427 |
| P50 | author | Claudine Isaacs | Q90579511 |
| P2093 | author name string | Elizabeth Kaufman | |
| Beth N Peshkin | |||
| Marc D Schwartz | |||
| Caryn Lerman | |||
| Clinton Finch | |||
| Tiffani DeMarco | |||
| Chanita Hughes | |||
| P433 | issue | 21 | |
| P921 | main subject | BRCA1 Mutation | Q28444960 |
| ovarian cancer | Q172341 | ||
| P304 | page(s) | 4034-4041 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing | |
| P478 | volume | 21 |
| Q48501655 | A Two-Phase Approach to Developing SNAP: an iPhone Application to Support Appointment Scheduling and Management for Women with a BRCA Mutation. |
| Q52016846 | Acceptance of preventive surgeries by Israeli women who had undergone BRCA testing. |
| Q50137319 | Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation |
| Q57314784 | Assessment of Psychosocial Outcomes in Genetic Counseling Research: An Overview of Available Measurement Scales |
| Q37011738 | Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations |
| Q81270429 | CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer |
| Q28383993 | Characterization of BRCA1 and BRCA2 mutations in a large United States sample |
| Q34017520 | Communicating genetic and genomic information: health literacy and numeracy considerations |
| Q36667556 | Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer |
| Q80246040 | Development of a communication aid to facilitate risk communication in consultations with unaffected women from high risk breast cancer families: a pilot study |
| Q26773707 | Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancer |
| Q36694081 | Estimating the survival benefits gained from providing national cancer genetic services to women with a family history of breast cancer. |
| Q46971163 | Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation. |
| Q35773039 | Genetic counseling content: How does it impact health behavior? |
| Q76394083 | Genetic testing for cancer susceptibility: the promise and the pitfalls |
| Q47771358 | Health beliefs and behaviors of women who have received genetic counseling for breast cancer |
| Q34116505 | International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers |
| Q35777905 | Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance |
| Q35565667 | Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns? |
| Q37688802 | Long-term satisfaction and quality of life following risk reducing surgery in BRCA1/2 mutation carriers |
| Q47973656 | Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer |
| Q35021170 | New Strategies in Ovarian Cancer: Uptake and Experience of Women at High Risk of Ovarian Cancer Who Are Considering Risk-Reducing Salpingo-Oophorectomy |
| Q37471829 | Patient compliance based on genetic medicine: a literature review. |
| Q33780087 | Patient responses to genetic information: studies of patients with hereditary cancer syndromes identify issues for use of genetic testing in nephrology practice |
| Q36610024 | Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up |
| Q34692294 | Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors |
| Q37109290 | Predictors of choosing life-long screening or prophylactic surgery in women at high and moderate risk for breast and ovarian cancer |
| Q79919779 | Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation |
| Q38252441 | Psychiatric implications of cancer genetic testing |
| Q45894751 | Psychosocial factors and uptake of risk-reducing salpingo-oophorectomy in women at high risk for ovarian cancer |
| Q51794096 | Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American kindred. |
| Q37185670 | Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing |
| Q50787069 | Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: a prospective cohort study. |
| Q36614506 | Surveillance of women at high risk for hereditary ovarian cancer is inefficient |
| Q55243290 | The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer. |
| Q82258287 | The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communication |
| Q34351382 | Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers |
| Q38599703 | Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea |
| Q34309892 | Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers |
| Q58080907 | Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study |
| Q37117139 | Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress. |
| Q33572852 | Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation. |
Search more.